Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1958 1
1959 1
1963 2
1964 1
1967 1
1968 1
1969 5
1970 1
1971 1
1972 1
1973 4
1974 3
1975 9
1976 18
1977 12
1978 11
1979 16
1980 16
1981 14
1982 19
1983 27
1984 21
1985 27
1986 39
1987 32
1988 28
1989 28
1990 28
1991 33
1992 38
1993 55
1994 43
1995 49
1996 57
1997 43
1998 60
1999 53
2000 67
2001 63
2002 72
2003 92
2004 83
2005 102
2006 112
2007 112
2008 118
2009 102
2010 108
2011 105
2012 128
2013 93
2014 102
2015 112
2016 89
2017 91
2018 96
2019 94
2020 99
2021 110
2022 84
2023 89
2024 86
2025 128
2026 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,122 results

Results by year

Filters applied: . Clear all
Page 1
Testosterone in women--the clinical significance.
Davis SR, Wahlin-Jacobsen S. Davis SR, et al. Lancet Diabetes Endocrinol. 2015 Dec;3(12):980-92. doi: 10.1016/S2213-8587(15)00284-3. Epub 2015 Sep 7. Lancet Diabetes Endocrinol. 2015. PMID: 26358173 Review.
Despite the crucial role of testosterone and the high circulating concentrations of this hormone relative to oestradiol in women, studies of its action and the effects of testosterone deficiency and replacement in women are scarce. The primary indicati …
Despite the crucial role of testosterone and the high circulating concentrations of this hormone relative to oestradiol in women …
Testosterone use for hypoactive sexual desire disorder in postmenopausal women.
Parish SJ, Kling JM. Parish SJ, et al. Menopause. 2023 Jul 1;30(7):781-783. doi: 10.1097/GME.0000000000002190. Epub 2023 Jun 13. Menopause. 2023. PMID: 37314872
Testosterone is an important evidence-based therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women. ...This Practice Pearl will discuss evidence-based testosterone therapy for management of HSDD in postmenopausal women....
Testosterone is an important evidence-based therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women. ...T …
Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Davis SR, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603. J Clin Endocrinol Metab. 2019. PMID: 31498871 Free PMC article.
This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The International Society for Sexual Medicine, The International Society for the Study of Women's Se …
This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause …
Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study.
Glynne S, Kamal A, Kamel AM, Reisel D, Newson L. Glynne S, et al. Arch Womens Ment Health. 2025 Jun;28(3):541-550. doi: 10.1007/s00737-024-01513-6. Epub 2024 Sep 16. Arch Womens Ment Health. 2025. PMID: 39283522 Free PMC article.
PURPOSE: The purpose of this study was to assess the impact of testosterone therapy on mood and cognitive symptoms in perimenopausal and postmenopausal women. METHODS: A retrospective cohort study undertaken in a UK specialist menopause clinic. 510 women …
PURPOSE: The purpose of this study was to assess the impact of testosterone therapy on mood and cognitive symptoms in perimenopausal …
Not just sex: other roles for testosterone in women.
Davis SR. Davis SR. Climacteric. 2025 Aug;28(4):373-376. doi: 10.1080/13697137.2024.2445301. Epub 2025 Jan 17. Climacteric. 2025. PMID: 39819275 Review.
Clinical trials have consistently demonstrated benefits of testosterone therapy on several domains of sexual function for postmenopausal women with low sexual desire causing substantial personal concern. Whether other benefits can be attributed to testosterone …
Clinical trials have consistently demonstrated benefits of testosterone therapy on several domains of sexual function for postmenopau …
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL. Hirschberg AL. J Clin Endocrinol Metab. 2023 Apr 13;108(5):1243-1253. doi: 10.1210/clinem/dgac673. J Clin Endocrinol Metab. 2023. PMID: 36409990 Free PMC article. Review.
Testosterone >5 nmol/L is associated with virilization and requires prompt investigation to rule out an androgen-producing tumor in the first instance. ...This review summarizes the most relevant causes of hyperandrogenism in postmenopausal women and suggests pri …
Testosterone >5 nmol/L is associated with virilization and requires prompt investigation to rule out an androgen-producing tumor i …
Testosterone use in postmenopausal women.
Martínez-García A, Davis SR. Martínez-García A, et al. Climacteric. 2021 Feb;24(1):46-50. doi: 10.1080/13697137.2020.1796961. Epub 2020 Jul 24. Climacteric. 2021. PMID: 32705895 Review.
The physiological, clinical and therapeutic aspects of testosterone in women's health are still a matter of controversy and debate. Quality evidence data of clinical trials favors the use of transdermal testosterone in postmenopausal women with …
The physiological, clinical and therapeutic aspects of testosterone in women's health are still a matter of controversy …
The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society. North American Menopause Society. Menopause. 2005 Sep-Oct;12(5):496-511; quiz 649. doi: 10.1097/01.gme.0000177709.65944.b0. Epub 2005 Sep 1. Menopause. 2005. PMID: 16145303 Review.
There are few data regarding the safety and efficacy of testosterone therapy in women not using concomitant estrogen therapy or for the use of testosterone therapy for longer than 6 months. Clinically available laboratory assays do not accurately detect te …
There are few data regarding the safety and efficacy of testosterone therapy in women not using concomitant estrogen therapy o …
Risks of Testosterone for Postmenopausal Women.
Pinkerton JV, Blackman I, Conner EA, Kaunitz AM. Pinkerton JV, et al. Endocrinol Metab Clin North Am. 2021 Mar;50(1):139-150. doi: 10.1016/j.ecl.2020.10.007. Epub 2021 Jan 11. Endocrinol Metab Clin North Am. 2021. PMID: 33518182 Review.
Transdermal testosterone therapy, dosed within premenopausal physiologic testosterone ranges, used alone or with menopausal hormone therapy for postmenopausal hypoactive sexual desire disorder, has shown short-term efficacy, with few androgenic side effects. …
Transdermal testosterone therapy, dosed within premenopausal physiologic testosterone ranges, used alone or with menopausal …
The use of testosterone after menopause.
Davis SR. Davis SR. J Br Menopause Soc. 2004 Jun;10(2):65-9. doi: 10.1258/136218004774202373. J Br Menopause Soc. 2004. PMID: 15207027 Review.
There is now substantial evidence from randomised controlled trials that testosterone therapy will improve sexual satisfaction and mood in surgically menopausal women treated with concurrent oestrogen, with less data in naturally menopausal women …
There is now substantial evidence from randomised controlled trials that testosterone therapy will improve sexual satisfaction and mo …
3,122 results